Discovery might inform new approach to Huntington's disease

Treatments that target a fragment of the mutant protein that causes Huntington's disease might be more effective than treatments—now in clinical trials—that target the whole protein but leave this fragment intact, a new ...

Mutant group B strep strains may explain infections in newborns

A new study could explain why some mothers can still pass Group B Streptococcus, or GBS, to their babies after childbirth even when they're treated with antibiotics. A Michigan State University research team discovered postpartum ...

page 1 from 40